Formulation for hGH and rhIGF-1 combination

Details for Australian Patent Application No. 2010321225 (hide)

Owner IPSEN Pharma S.A.S.

Inventors Gopinath, Enona; Park, Susan; Arakawa, Tsutomu; Richard, Joel; Fais, Fabio

Agent Watermark

Pub. Number AU-A-2010321225

PCT Pub. Number WO2011/060922

Priority 61/261,859 17.11.09 US

Filing date 17 November 2010

Wipo publication date 26 May 2011

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/060922 Priority application(s): WO2011/060922

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321233-Package for tobacco-related articles

2010321223-Process for the production of fine chemicals